Arcturus Therapeutics Holdings Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arcturus Therapeutics Holdings Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Arcturus Therapeutics Holdings Inc. Return On Equity for the quarter ending September 30, 2024 was -23.6 %, a 169% decline year-over-year.
  • Arcturus Therapeutics Holdings Inc. annual Return On Equity for 2023 was -10.1 %, a 309% decline from 2022.
  • Arcturus Therapeutics Holdings Inc. annual Return On Equity for 2022 was 4.85 %.
  • Arcturus Therapeutics Holdings Inc. annual Return On Equity for 2021 was -71.1 %, a 89.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -10.1 -15 -309% Jan 1, 2023 Dec 31, 2023
2022 4.85 +76 Jan 1, 2022 Dec 31, 2022
2021 -71.1 -33.6 -89.4% Jan 1, 2021 Dec 31, 2021
2020 -37.6 +78.4 +67.6% Jan 1, 2020 Dec 31, 2020
2019 -116 +3.19 +2.68% Jan 1, 2019 Dec 31, 2019
2018 -119 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.